Creative Medical Technology Holdings, Inc. Earnings Per Share (Basic)
Creative Medical Technology Holdings, Inc. (CELZ) reported Earnings Per Share (Basic) of -$0.93 per share for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2023-03-31
- Creative Medical Technology Holdings, Inc. earnings per share, basic for the quarter ending 2022-09-30 was -$0.07.
- Creative Medical Technology Holdings, Inc. earnings per share, basic for the quarter ending 2022-06-30 was -$0.20.
- Creative Medical Technology Holdings, Inc. earnings per share, basic for the quarter ending 2022-03-31 was -$0.18, a 101.47% decline year-over-year.
- Creative Medical Technology Holdings, Inc. earnings per share, basic for the quarter ending 2021-12-31 was -$1.11.
- Creative Medical Technology Holdings, Inc. earnings per share, basic for fiscal 2022 was -$0.93, a 112.62% decline from fiscal 2021.
- Creative Medical Technology Holdings, Inc. earnings per share, basic for fiscal 2021 was $7.37.
- Creative Medical Technology Holdings, Inc. earnings per share, basic for fiscal 2020 was -$62.69.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2022-12-31 | -$0.93 10-K · filed 2023-03-31 | |||
| 2022-09-30 | -$0.07 10-Q · filed 2022-11-10 | -$0.40 10-Q · filed 2022-11-10 | ||
| 2022-06-30 | -$0.20 10-Q · filed 2022-08-12 | -$0.38 10-Q · filed 2022-08-12 | ||
| 2022-03-31 | -$0.18 10-Q · filed 2022-05-13 | |||
| 2021-12-31 | -$1.11 derived: net income ÷ weighted average shares · filed 2023-03-31 | -$1.93 derived: net income ÷ weighted average shares · filed 2023-03-31 | -$3.13 derived: net income ÷ weighted average shares · filed 2023-03-31 | $7.37 10-K · filed 2023-03-31 |
| 2021-09-30 | -$0.75 10-Q · filed 2022-11-10 | -$1.99 derived: net income ÷ weighted average shares · filed 2022-11-10 | $9.98 10-Q · filed 2022-11-10 | |
| 2021-06-30 | -$1.25 10-Q · filed 2022-08-12 | $11.12 10-Q · filed 2022-08-12 | ||
| 2021-03-31 | $12.22 10-Q · filed 2022-05-13 | |||
| 2020-12-31 | -$62.69 10-K · filed 2022-03-30 | |||
| 2020-09-30 | $0.00 10-Q · filed 2020-11-13 | -$0.02 derived: net income ÷ weighted average shares · filed 2021-11-15 | $0.01 10-Q · filed 2020-11-13 | |
| 2020-06-30 | -$0.01 10-Q · filed 2020-08-14 | $0.02 10-Q · filed 2020-08-14 | ||
| 2020-03-31 | $0.09 10-Q · filed 2020-05-15 | |||
| 2019-09-30 | $0.00 10-Q · filed 2020-11-13 | $0.00 10-Q · filed 2020-11-13 | ||
| 2019-06-30 | -$0.01 10-Q · filed 2020-08-14 | -$0.13 10-Q · filed 2020-08-14 | ||
| 2019-03-31 | -$0.12 10-Q · filed 2020-05-15 | |||
| 2013-03-31 | -$0.00 derived: net income ÷ weighted average shares · filed 2014-05-13 | |||
| 2012-03-31 | -$0.00 derived: net income ÷ weighted average shares · filed 2013-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |